Clinical trial
Temozolomide in Treating Patients With Solid Tumors That Have Spread to the…
NCT00012116 · Jonsson Comprehensive Cancer Center, Other · Completed
Key facts
| NCT number | NCT00012116 |
|---|---|
| Title | Temozolomide in Treating Patients With Solid Tumors That Have Spread to the Brain |
| Official title | Temozolomide For Patients With Cerebral Metastases Who Have Failed Radiation Therapy |
| Lead sponsor | Jonsson Comprehensive Cancer Center, Other |
| Collaborators | Schering-Plough Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Metastatic Cancer |
| Intervention type | Drug |
| Interventions | temozolomide |
| Enrollment | 4 |
| Start date | Oct 1, 2000 |
| Primary completion | Apr 1, 2002 |
| Completion | Apr 1, 2002 |
| First posted | Jan 1, 2004 |
| Last update posted | Aug 3, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: